Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Ranger Energy Stock: Strong EBITDA, But Cash Conversion Is The Problem (NYSE:RNGR)

29 August 2026

Summit Midstream Stock: Strong Potential From Improving Leverage EBITDA Growth (NYSE:SMC)

29 August 2026

BOC Hong Kong (Holdings) Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:BHKLY) 2026-08-28

29 August 2026

Dividend Champion, Contender, And Challenger Highlights: Week August 30

29 August 2026

Central Asia Metals plc (CAMLF) Q2 2026 Earnings Call Transcript

29 August 2026
Facebook X (Twitter) Instagram
Business Saturday, Aug 29
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Cue: The Market Is Paying $86M For A Drug It Doesn’t Own (NASDAQ:CUE)
News

Cue: The Market Is Paying $86M For A Drug It Doesn’t Own (NASDAQ:CUE)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk10 July 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Cue: The Market Is Paying M For A Drug It Doesn’t Own (NASDAQ:CUE)
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Maya is a lawyer by training whose research centres on under-followed US micro-cap and small-cap equities, with particular emphasis on capital structure, capital allocation, and corporate governance. A graduate of NALSAR University of Law (B.A. LL.B. Hons.), she brings a disclosure-first, forensic approach to equity analysis — reading filings the way a lawyer reads a record. Her legal background sharpens her work on M&A activity, related-party dealings, second-step conversions, and the quality of corporate disclosure, areas that market participants without a legal grounding often underweight. On Seeking Alpha, Maya writes primarily on small and micro-cap names, both long and short, with bank and thrift balance sheets a current area of focus. She is especially drawn to situations where management’s narrative diverges from what the numbers and the governance actually support — the place where legal and structural scrutiny adds a dimension that purely quantitative screens miss. Her writing aims to be honest, data-driven, and contrarian where the evidence supports it, rather than consensus-chasing.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Ranger Energy Stock: Strong EBITDA, But Cash Conversion Is The Problem (NYSE:RNGR)

Summit Midstream Stock: Strong Potential From Improving Leverage EBITDA Growth (NYSE:SMC)

BOC Hong Kong (Holdings) Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:BHKLY) 2026-08-28

Dividend Champion, Contender, And Challenger Highlights: Week August 30

Central Asia Metals plc (CAMLF) Q2 2026 Earnings Call Transcript

Union Pacific: M&A Optionality Isn’t Enough To Justify Buying At Fair Value (NYSE:UNP)

Tenaga Nasional Berhad (TNABY) Q2 2026 Earnings Call Transcript

MasTec: Superior Adds Another Growth Engine As Earnings Accelerate (NYSE:MTZ)

PEY: Attractive Value And Growth Setup For Invesco’s High-Yield Dividend Achievers ETF

Editors Picks

Summit Midstream Stock: Strong Potential From Improving Leverage EBITDA Growth (NYSE:SMC)

29 August 2026

BOC Hong Kong (Holdings) Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:BHKLY) 2026-08-28

29 August 2026

Dividend Champion, Contender, And Challenger Highlights: Week August 30

29 August 2026

Central Asia Metals plc (CAMLF) Q2 2026 Earnings Call Transcript

29 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Union Pacific: M&A Optionality Isn’t Enough To Justify Buying At Fair Value (NYSE:UNP)

29 August 2026

Tenaga Nasional Berhad (TNABY) Q2 2026 Earnings Call Transcript

28 August 2026

MasTec: Superior Adds Another Growth Engine As Earnings Accelerate (NYSE:MTZ)

28 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.